Search

Your search keyword '"Morizane, Chigusa"' showing total 881 results

Search Constraints

Start Over You searched for: Author "Morizane, Chigusa" Remove constraint Author: "Morizane, Chigusa"
881 results on '"Morizane, Chigusa"'

Search Results

4. Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of pancreatic cancer

5. What is the gender representation in authorship in later phase systemic clinical trials in biliary tract cancer (BTC)? - a retrospective review of the published literature.

6. Development of a nomogram to predict survival in advanced biliary tract cancer

8. Factors Affecting Nonfunctioning Small Pancreatic Neuroendocrine Neoplasms and Proposed New Treatment Strategies

9. Efficacy of endoscopic ultrasound-guided tissue acquisition for solid pancreatic lesions 20 mm or less in diameter suspected as neuroendocrine tumors or requiring differentiation

10. Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study

11. Clinical significance of circulating-tumour DNA analysis by metastatic sites in pancreatic cancer

13. Identification of activity-based biomarkers for early-stage pancreatic tumors in blood using single-molecule enzyme activity screening

15. Proportion of unresectable pancreatic cancer specimens obtained by endoscopic ultrasound-guided tissue acquisition meeting the OncoGuide™ NCC Oncopanel System analysis suitability criteria: a single-arm, phase II clinical trial

16. A novel endoscopic technique using fully covered self-expandable metallic stents for benign strictures after hepaticojejunostomy: the saddle-cross technique (with video)

19. Efficacy of endoscopic ultrasound‐guided gastroenterostomy using self‐expandable metallic stent for afferent loop syndrome: A single‐center retrospective study

21. Phase II trial of niraparib for BRCA-mutated biliary tract, pancreatic and other gastrointestinal cancers: NIR-B

22. Diagnostic performance of EUS-guided tissue acquisition for solid pancreatic lesions ≤10 mm

23. Factors affecting nonfunctioning small pancreatic neuroendocrine neoplasms and proposed new treatment strategies

24. Feasibility and safety of a novel plastic stent designed specifically for endoscopic ultrasound-guided pancreatic duct drainage: a case series

25. The clinical outcomes of combination chemotherapy in elderly patients with advanced biliary tract cancer: an exploratory analysis of JCOG1113

29. JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis

32. Brightline-2: a phase IIa/IIb trial of brigimadlin (BI 907828) in advanced biliary tract cancer, pancreatic ductal adenocarcinoma or other solid tumors.

34. Efficacy of biomarker-matched therapy in clinical trials for advanced gastrointestinal cancers: A pooled analysis of SCRUM-Japan studies.

35. Pivotal single-arm, phase 2 trial of tasurgratinib for patients with fibroblast growth factor receptor (FGFR)-2 gene fusion-positive cholangiocarcinoma (CCA).

36. Comprehensive clinico-molecular profile and efficacy of anti-HER2 therapy for HER2-amplified biliary tract cancer.

37. Prognostic factors for overall survival in patients with advanced digestive neuroendocrine carcinoma treated with first-line cisplatin-based chemotherapy: A post-hoc analysis of JCOG1213.

38. Clinical characteristics and the course of hepatobiliary and pancreatic malignant tumors with high microsatellite instability after pembrolizumab administration: A multicenter observational study.

39. Study protocol for a prospective, multicentre, phase II trial on endoscopic treatment using two fully covered self-expandable metallic stents for benign strictures after hepaticojejunostomy

40. Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of pancreatic cancer

42. PS3-5 Futibatinib for intrahepatic cholangiocarcinoma with FGFR2 fusions/rearrangements: Japanese sub-analysis of FOENIX-CCA2

44. Risk stratification and prognostic factors in patients with unresectable undifferentiated carcinoma of the pancreas

45. Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study)

47. Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies

48. Pancreatic neuroendocrine carcinoma G3 may be heterogeneous and could be classified into two distinct groups

50. A telephone follow-up management model for oral outpatient chemotherapy featuring concerted interventions by hospital and community pharmacists, and physicians

Catalog

Books, media, physical & digital resources